516 related articles for article (PubMed ID: 31918229)
1. Could 3D models of cancer enhance drug screening?
Brancato V; Oliveira JM; Correlo VM; Reis RL; Kundu SC
Biomaterials; 2020 Feb; 232():119744. PubMed ID: 31918229
[TBL] [Abstract][Full Text] [Related]
2. Microengineered 3D Tumor Models for Anti-Cancer Drug Discovery in Female-Related Cancers.
Amirghasemi F; Adjei-Sowah E; Pockaj BA; Nikkhah M
Ann Biomed Eng; 2021 Aug; 49(8):1943-1972. PubMed ID: 33403451
[TBL] [Abstract][Full Text] [Related]
3. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
[TBL] [Abstract][Full Text] [Related]
4. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
5. Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.
Shukla P; Yeleswarapu S; Heinrich MA; Prakash J; Pati F
Biofabrication; 2022 May; 14(3):. PubMed ID: 35512666
[TBL] [Abstract][Full Text] [Related]
6. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
[TBL] [Abstract][Full Text] [Related]
7. Patient-Derived Organoids as a Model for Cancer Drug Discovery.
Rae C; Amato F; Braconi C
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801782
[TBL] [Abstract][Full Text] [Related]
8. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
9. The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening.
Fröhlich E
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108283
[TBL] [Abstract][Full Text] [Related]
10. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches.
van Rijt A; Stefanek E; Valente K
Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760435
[TBL] [Abstract][Full Text] [Related]
11. 3D breast cancer microtissue reveals the role of tumor microenvironment on the transport and efficacy of free-doxorubicin in vitro.
Brancato V; Gioiella F; Imparato G; Guarnieri D; Urciuolo F; Netti PA
Acta Biomater; 2018 Jul; 75():200-212. PubMed ID: 29864516
[TBL] [Abstract][Full Text] [Related]
12. Influences of the 3D microenvironment on cancer cell behaviour and treatment responsiveness: A recent update on lung, breast and prostate cancer models.
Costard LS; Hosn RR; Ramanayake H; O'Brien FJ; Curtin CM
Acta Biomater; 2021 Sep; 132():360-378. PubMed ID: 33484910
[TBL] [Abstract][Full Text] [Related]
13. Recapitulating Tumor Microenvironment Using AXTEX-4DTM for Accelerating Cancer Research and Drug Screening.
Baru A; Mazumder S; Kundu PK; Sharma S; Das Purkayastha BP; Khan S; Gupta R; Mehrotra Arora N
Asian Pac J Cancer Prev; 2022 Feb; 23(2):561-571. PubMed ID: 35225469
[TBL] [Abstract][Full Text] [Related]
14. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
[TBL] [Abstract][Full Text] [Related]
15. Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation.
Singh M; Close DA; Mukundan S; Johnston PA; Sant S
Assay Drug Dev Technol; 2015 Nov; 13(9):570-83. PubMed ID: 26274587
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiologically relevant in vitro tumor models for drug screening.
Das V; Bruzzese F; Konečný P; Iannelli F; Budillon A; Hajdúch M
Drug Discov Today; 2015 Jul; 20(7):848-55. PubMed ID: 25908576
[TBL] [Abstract][Full Text] [Related]
17. 3D bioprinting for drug discovery and development in pharmaceutics.
Peng W; Datta P; Ayan B; Ozbolat V; Sosnoski D; Ozbolat IT
Acta Biomater; 2017 Jul; 57():26-46. PubMed ID: 28501712
[TBL] [Abstract][Full Text] [Related]
18. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
Amoedo ND; Obre E; Rossignol R
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
[TBL] [Abstract][Full Text] [Related]
20. 3D bioprinting as an emerging standard for cancer modeling and drug testing.
Molander D; Sbirkov Y; Sarafian V
Folia Med (Plovdiv); 2022 Aug; 64(4):559-565. PubMed ID: 36045467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
